Food and Drug Administration‬‬
‪‪Food and Drug Administration‬‬

FDA requests removal of Opana ER for risks related to abuse

Posted on

In the present day, the U.S. Meals and Drug Administration requested that Endo Prescription drugs take away its opioid ache medicine, reformulated Opana ER (oxymorphone hydrochloride), from the market. After cautious consideration, the company is searching for elimination based mostly on its concern that the advantages of the drug could not outweigh its dangers. That is the primary time the company has taken steps to take away a at the moment marketed opioid ache treatment from sale as a result of public well being penalties of abuse.

‪‪Food and Drug Administration‬‬

Other articles you might like;

‪‪Food and Drug Administration‬‬

Leave a Reply

Your email address will not be published. Required fields are marked *